Nordic BioSite Exhibits Extensive Molecular Biology Portfolio at NBS 2018

Täby, Sweden: – Nordic BioSite, the leading Scandinavian supplier of validated biotechnology products, will once again be a leading presence as sponsor and exhibitor at January’s annual Norwegian Biochemical Society Contact Meeting (NBS 2018).

The Nordic BioSite team will be exhibiting a wide range of its newest and most popular products for molecular biological research, including its line of ZymoPURE™ Midi, Maxi & Giga Plasmid Prep Kits that enable users to produce ultra-pure endotoxin-free plasmid DNA in less than 20 minutes with a yield of 300-1200 μg per sample.

Molecular Biology Support

BioSite’s Area Manager for Norway, Dr. Johanna Gottschamel, will lead BioSite’s presence at the event, along with Danish area representative Dr. Karen O’Hanlon Cohrt.

“We believe our display will be of very high interest to the researchers, group leaders, and students working within the field of molecular biology that form the core audience for the NBS contact meeting,” said Dr. Gottschamel.

“We attend NBS every year and are proud to be sponsors of this great event,” she added.

Optimized Solutions

“The contact meeting is a great opportunity to meet existing customers, establish relationships with new potential partners, and to demonstrate how we support research with high quality supplies and products,” said Dr. O’Hanlon Cohrt.

“These include a series of products highly relevant to NBS areas of research including tools for molecular biology, microbiomics, PCR and NextGen sequencing,” she commented.

“In this respect, we believe that our portfolio of solutions from ZymoBIOMICS® that offers standardized microbiomics solutions for optimizing workflows from collection to conclusion will prove particularly interesting, with a choice of microbial standards, sample collection & preservation devices, DNA and RNA isolation kits, PCR and quantification kits, and microbiomics sequencing Services,” Dr. O’Hanlon Cohrt added.

About Nordic BioSite

Since the late 1990s, Nordic BioSite (BioSite) has become recognized as one of the pharma industry’s most innovative and customer-responsive supplier of high quality validated biotechnology products for research, diagnostics, immunology and molecular biology.

The company serves pharmaceutical, biotech, diagnostic and academic organizations with more than two million unique products in more than 30 different groups, ranging from antibodies to genetic vectors. These are sourced from selected manufacturers and laboratories in Europe, the Americas and Asia.

BioSite continuously introduces new products as a result of its own R&D, leveraged by close partnerships with manufacturers and feedback from customers.

Nordic BioSite’s company strapline, By Your Side™, defines a company ethos of partnering life science customers, helping to find the right products and services, so that researchers can achieve their goals across the whole spectrum of research.

BioSite also operates as a CRO through its Finnish-based cGLP laboratory, BioSiteHisto. BioSiteHisto offers a range of cutting-edge custom laboratory services including histology (e.g., immunohistochemistry and immunofluorescence methods), sample processing for histology, imaging and image analysis, and antibody validation.

About NBS 2018

The Norwegian Biochemical Society Contact Meeting (NBS 2018) provides a scientific forum and networking platform for researchers and students working in biochemistry, cell biology, molecular biology, and molecular medicine in Norway. The 2018 conference is a four-day event opening January 18 at Scandic Hafjell, Øyer, near Lillehammer in central Norway.

The conference will feature ten plenary lectures, with eminent keynote speakers from Norway, the UK and USA. The programme also features a number of topic-focused Minisessions.

The NBS meeting is sponsored by five leading international companies, including Nordic BioSite, and features a commercial exhibition.

The event is organised by NBS Oslo with more information at: www.biokjemisk.no/contact-meeting-2018/.